Company Description
Surgalign Holdings, Inc., a medical technology company, specializes in designing, developing, manufacturing, and distributing biologic, metal, and synthetic implants globally. Their product offerings include the coflex interlaminar stabilization device for lumbar spinal stenosis treatment, the simmetry sacroiliac joint fusion system to reduce pain and disability, and the fortilink ibf system with Tetrafuse 3D technology. Surgalign's implants are used in orthopedic, spine, sports medicine, plastic surgery, trauma, and other surgical procedures to repair and promote natural healing. The company markets its products through direct distribution and OEM relationships to healthcare providers, hospitals, and other facilities, as well as through independent distributors. Founded in 1997 and headquartered in Deerfield, IL, Surgalign is dedicated to advancing digital health solutions for superior clinical and economic outcomes worldwide.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Surgalign Holdings.